Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.

Current cancer drug targets - 1 Jan 2021

Alimardani Maliheh, Moghbeli Meysam, Rastgar-Moghadam Azam, Shandiz Fatemeh Homaei, Abbaszadegan Mohammad Reza

Abstract excerpt

BACKGROUND: Breast cancer (BC) is known as the most common malignancy in women. Environmental and genetic factors are associated with BC progression. Genetic polymorphisms have been reported as important risk factors for BC prognosis and drug response. Main Body: In the present review, we have summarized all of the single nucleotide polymorphisms (SNPs) which have been significantly associated with drug response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Identifiers

PMID: 34036920
DOI: 10.2174/1568009621666210525151846

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.PMID 34036920Read ↗

Toxicity and Pharmacogenomic Biomarkers in Breast Cancer ChemotherapySemantic proximity Read ↗

The effect of genetic variability on drug response in conventional breast cancer treatment.Semantic proximity Read ↗

Pharmacogenomics in breast cancer: current trends and future directions.Semantic proximity Read ↗

Are pharmacogenomic biomarkers an effective tool to predict taxane toxicity and outcome in breast cancer patients? Literature review.Semantic proximity Read ↗

Association between single nucleotide polymorphisms of DNA damage response pathway genes and increased risk in breast cancer.Semantic proximity Read ↗

LncRNA polymorphisms and breast cancer risk.Semantic proximity Read ↗

Predictive role of single nucleotide polymorphism (rs11614913) in the development of breast cancer in Pakistani population.Semantic proximity Read ↗

Genomic Variants and Worldwide Epidemiology of Breast Cancer: A Genome-Wide Association Studies Correlation Analysis.Semantic proximity Read ↗

CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: a case-control study.Semantic proximity Read ↗

Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?Semantic proximity Read ↗

[Correlation between single nucleotide polymorphisms and hematological malignancies].Semantic proximity Read ↗

Pharmacogenetics as a Future Tool to Risk-Stratify Breast Cancer Patients According to Chemotoxicity Potential from the Doxorubicin Hydrochloride and Cyclophosphamide (AC) RegimenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.